France-based Biotech Open Platform (BIOP) has inaugurated its industrial biotechnology platform at the Sustainable Materials Centre, inside Michelin’s Innovation Park - Cataroux in Clermont-Ferrand, France. The facility has begun taking on its first advanced fermentation projects. The first phase involved an investment of more than €20-mn (over $22-mn).
BIOP was created in 2024 by Danone (French food & beverage firm), Michelin (French tyre maker), DMC Biotechnologies (US-based biotech firm), Crédit Agricole Centre France (French cooperative bank), Clermont Auvergne Innovation (technology transfer subsidiary of Clermont Auvergne University and INRAE) and Greentech (French biotech company).
Even as numerous biotechnology innovations demonstrate promising results in the laboratory, many never progress beyond that stage. Between proof of concept and industrial deployment lies a critical step: scale-up. BIOP was created specifically to address this challenge.
The platform is aimed at bridging the gap between laboratory development and industrial-scale production. It supports start-ups, industrial companies and R&D organisations in developing, optimising, scaling up and validating fermentation-based processes. It has a complete fermentation line with capacity of up to 15-m³ and semi-industrial purification systems. It also offers bioprocess development capabilities, built to standards including those applicable to food production. BIOP said the platform can produce volumes large enough for application testing and for the validation stages that precede commercial production.
The platform is intended for advanced fermentation, including precision fermentation, which uses yeasts, bacteria, microalgae and fungi to make proteins, enzymes, food ingredients, cosmetic actives and bio-based materials. End-use sectors include food & beverages, cosmetics, agriculture, chemicals and biomaterials.
BIOP has its own dedicated teams and infrastructure and says it ensures strict project confidentiality and protection of intellectual property. The project also received support from the European Union through the European Regional Development Fund, managed by the Auvergne-Rhône-Alpes Region, and from Clermont Auvergne Métropole.
“Scale-up requires experience, technical know-how and the ability to solve the issues that appear as the process moves from one scale to another,” said Ms. Khadidja Romari, Chief Executive Officer of BIOP. She said equipment alone is not enough and that BIOP’s role is to help companies move faster and more securely towards industrialisation.
Mr. Florent Menegaux, Chairman of the Michelin Group, said the platform gives Michelin a chance to explore replacing certain petrochemical-derived molecules with bio-based alternatives.
Mr. Jim Flatt, CEO of DMC Biotechnologies, said access to capabilities that can show an innovation can be produced reliably and competitively at greater scale is one of the main barriers to industrial biotechnology.
Mr. Antoine de Saint-Affrique, CEO of Danone, said the platform strengthens a critical link in Europe’s biotechnology ecosystem by speeding up the industrial scale-up of laboratory innovations.


1 October, 2026 16:59:02 IST 
















